
1. sci transl med. 2014 aug 27;6(251):251ra117. doi: 10.1126/scitranslmed.3009793.

loss dysfunction vδ2⁺ γδ cells associated clinical tolerance to
malaria.

jagannathan p(1), kim cc(1), greenhouse b(1), nankya f(2), bowen k(1),
eccles-james i(1), muhindo mk(2), arinaitwe e(2), tappero jw(3), kamya mr(4),
dorsey g(1), feeney me(5).

author information: 
(1)department medicine, san francisco general hospital, university of
california, san francisco, san francisco, ca 94110, usa.
(2)infectious diseases research collaboration, p.o. box 7475, kampala, uganda.
(3)center global health, centers disease control prevention, atlanta,
ga 30333, usa.
(4)department medicine, makerere university college health sciences, p.o.
box 7051, kampala, uganda.
(5)department medicine, san francisco general hospital, university of
california, san francisco, san francisco, ca 94110, usa. department of
pediatrics, university california, san francisco, san francisco, ca 94110,
usa. margaret.feeney@ucsf.edu.

although clinical immunity malaria eventually develops among children living
in endemic settings, underlying immunologic mechanisms known. the
vδ2(+) subset γδ cells intrinsic reactivity malaria antigens, can
mediate killing plasmodium falciparum merozoites, expand markedly vivo 
after malaria infection previously naïve hosts, role mediating
immunity children repeatedly exposed malaria unclear. evaluated γδ 
cell responses malaria among 4-year-old children enrolled longitudinal
study uganda. found repeated malaria associated reduced
percentages vδ2(+) γδ cells peripheral blood, decreased proliferation and
cytokine production response malaria antigens, increased expression 
immunoregulatory genes. further, loss dysfunction proinflammatory vδ2(+)
γδ cells associated reduced likelihood symptoms upon subsequent 
p. falciparum infection. together, results suggest repeated malaria
infection childhood results progressive loss dysfunction vδ2(+) 
γδ cells may facilitate immunological tolerance parasite.

copyright © 2014, american association advancement science.

doi: 10.1126/scitranslmed.3009793 
pmcid: pmc4198150
pmid: 25163477  [indexed medline]

